Medical equipments, pharmaceuticals and personal care products. To provide a treatment for exposure to Botulinum serotypes A, B, C, D, E, F, or G on the basis of the procurment Heptavalent Botulinum Anti-toxin via a 2 year supply contract with Emergent BioSolutions Inc.